UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Suggestions for Model‐Informed Precision Dosing to Optimize Neonatal Drug Therapy

Journal of clinical pharmacology, 2019-02, Vol.59 (2), p.168-176

2019

Volltextzugriff (PDF)

A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome

The Journal of pediatrics, 2016-03, Vol.170, p.39-44.e1

2016

Volltextzugriff (PDF)

Fatty Acids Regulate Stress Resistance and Virulence Factor Production for Listeria monocytogenes

Journal of Bacteriology, 2012-10, Vol.194 (19), p.5274-5284

2012

Volltextzugriff (PDF)

Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae

PLoS pathogens, 2008-12, Vol.4 (12), p.e1000241-e1000241

2008

Volltextzugriff (PDF)

Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling

Pharmaceutics, 2024-03, Vol.16 (3), p.375

2024

Volltextzugriff (PDF)

Simvastatin is protective during Staphylococcus aureus pneumonia

Current pharmaceutical biotechnology, 2011-09, Vol.12 (9), p.1455-1462

2011

Volltextzugriff (PDF)

Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding

Scientific reports, 2016-10, Vol.6 (1), p.34913-34913, Article 34913

2016

Volltextzugriff (PDF)

Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice

American journal of respiratory cell and molecular biology, 2013-11, Vol.49 (5), p.845-854

2013

Volltextzugriff (PDF)

Surfactant phospholipids act as molecular switches for premature induction of quorum sensing-dependent virulence in Pseudomonas aeruginosa

Virulence, 2020-12, Vol.11 (1), p.1090-1107

2020

Volltextzugriff (PDF)

Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection

American journal of physiology. Lung cellular and molecular physiology, 2009-07, Vol.297 (1), p.L64-L72

2009

Volltextzugriff (PDF)

Decreasing birth asphyxia: utility of statistical process control in a low-resource setting

BMJ open quality, 2018, Vol.7 (3), p.e000231-e000231

2018

Volltextzugriff (PDF)

Utility of Repeat Testing for Congenital Hypothyroidism in Infants with Very Low Birth Weight

The Journal of pediatrics, 2022-03, Vol.242, p.152-158.e1

2022

Volltextzugriff (PDF)

Vitamin D status of early preterm infants and the effects of vitamin D intake during hospital stay

Archives of disease in childhood. Fetal and neonatal edition, 2014-03, Vol.99 (2), p.F166-F168

2014

Volltextzugriff (PDF)

Antimicrobial Activity of Native and Synthetic Surfactant Protein B Peptides

Journal of Immunology, 2006-01, Vol.176 (1), p.416-425

2006

Volltextzugriff (PDF)

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome

Clinical pharmacokinetics, 2021-02, Vol.60 (2), p.249-259

2021

Volltextzugriff (PDF)

A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome

Pharmacology & therapeutics (Oxford), 2022-06, Vol.234, p.108045-108045, Article 108045

2022

Volltextzugriff (PDF)

Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BN

The Journal of immunology (1950), 2015-08, Vol.195 (4), p.1628-1636

2015

Volltextzugriff (PDF)

Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome

Clinical pharmacology and therapeutics, 2022-02, Vol.111 (2), p.496-508

2022

Volltextzugriff (PDF)

Host Defense Proteins on the Surface of Neonatal Skin: Implications for Innate Immunity

The Journal of pediatrics, 2008-06, Vol.152 (6), p.777-781

2008

Volltextzugriff (PDF)

Surfactant Protein B Inhibits Endotoxin-Induced Lung Inflammation

American journal of respiratory cell and molecular biology, 2003-03, Vol.28 (3), p.373-378

2003

Volltextzugriff (PDF)

Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P

Biochemical journal, 2004-06, Vol.380 (Pt 2), p.385-392

2004

Volltextzugriff (PDF)

Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics

Expert opinion on drug metabolism & toxicology, 2021-01, Vol.17 (1), p.87-103

2021

Volltextzugriff (PDF)

The Peptidoglycan-Degrading Property of Lysozyme Is Not Required for Bactericidal Activity In Vivo

Journal of Immunology, 2006-07, Vol.177 (1), p.519-526

2006

Volltextzugriff (PDF)

Surfactant Protein B Propeptide Contains a Saposin-Like Protein Domain with Antimicrobial Activity at Low pH

The Journal of immunology (1950), 2010-01, Vol.184 (2), p.975-983

2010

Volltextzugriff (PDF)

The effects of gestational age and birth weight on false-positive newborn-screening rates

Pediatrics (Evanston), 2010-11, Vol.126 (5), p.910-916

2010

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(64)
Buchkapitel
(2)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Suggestions for Model‐Informed Precision Dosing to Optimize Neonatal Drug Therapy

A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome

Fatty Acids Regulate Stress Resistance and Virulence Factor Production for Listeria monocytogenes

Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae

Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling

Simvastatin is protective during Staphylococcus aureus pneumonia

Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding

Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice

Surfactant phospholipids act as molecular switches for premature induction of quorum sensing-dependent virulence in Pseudomonas aeruginosa

Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection

Decreasing birth asphyxia: utility of statistical process control in a low-resource setting

Utility of Repeat Testing for Congenital Hypothyroidism in Infants with Very Low Birth Weight

Vitamin D status of early preterm infants and the effects of vitamin D intake during hospital stay

Antimicrobial Activity of Native and Synthetic Surfactant Protein B Peptides

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome

A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome

Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BN

Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome

Host Defense Proteins on the Surface of Neonatal Skin: Implications for Innate Immunity

Surfactant Protein B Inhibits Endotoxin-Induced Lung Inflammation

Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P

Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics

The Peptidoglycan-Degrading Property of Lysozyme Is Not Required for Bactericidal Activity In Vivo

Surfactant Protein B Propeptide Contains a Saposin-Like Protein Domain with Antimicrobial Activity at Low pH

The effects of gestational age and birth weight on false-positive newborn-screening rates

Suchergebnisse filtern